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I am delighted to inform you of some of the activities and
accomplishments of the research community at Maine
Medical Center in 2018. Coming on the heels of several years
of increased funding from NIH and other agencies, 2018 has
been one of dedicated engagement by our investigators and
scientific staff in their laboratories and in our communities
to implement their exciting research projects.
A few examples include the clinical trial of early tracheostomy in patients who
have suffered severe stoke now being conducted in our intensive care units under
the leadership of David Seder, the maturation of several projects conducted by
our junior investigators on the Center of Biomedical Research Excellence Award
directed by Lucy Liaw, and the implementation of the Northern New England
Clinical and Translational Research Network led by Cliff Rosen in collaboration
with colleagues at the University of Vermont School of Medicine and the University
of Southern Maine (graphic, p. 3).
Community engagement forms the basis of and is integral to many programs
recently implemented, as typified by the Maine Lung Cancer Coalition and the
Maine Cancer Genomics initiative based in our Center for Outcomes Research and
Evaluation and led by Paul Han. It is also the hallmark of several research programs
in our Center for Psychiatric Research, where Matt Siegel and his team are using
biosensor technology to improve the care of autistic individuals, and where Kristen
Woodberry is enhancing the engagement of family in the care of patients with early
psychosis disorders. Another example highlighted herein is the dedicated work of
Alexa Craig to develop a state-wide video communication system to optimize the
assessment and care of newborns with brain injuries incurred during birth.
Expanding community engagement has also been the focus of our education and
training programs. Grants received in 2017 from the American Heart Association
and the Maine Community Foundation are now supporting the expansion of our
summer internship program and high school education program in order to reach
students from underserved communities in rural Maine.

Cover photo from Dr. Michaela Reagan’s Lab. 3D Silk Scaffold Confocal Image using stains for human
white adipose (fat) tissue taken from liposuction samples, on silk scaffolds. Green stains are cell
filaments, red stains are lipids, and purple/blue is autofluorescence of scaffold.

I am immensely proud and appreciative of the outstanding work of these programs.
This focus on engagement and community is helping us chart a course for how we
can best support colleagues across MaineHealth in our newly unified health system.
I hope you enjoy taking a closer look at the research and the individuals conducting
this tremendous work.
Sincerely,

Back cover from Josh Boucher PhD, Staff Scientist Liaw Lab. Human retinal endothelial cells (cells that
form the linings of blood vessels) were coated to fibrin beads and allowed to form sprouting blood
vessels through the process of angiogenesis over 7 days.
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Don St. Germain, MD
Director & Vice President of Research
Maine Medical Center Research Institute
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In 2017 MMCRI received $20M from the National Institutes of Health to establish
a Northern New England Clinical & Translational Research Network (NNE-CTR).
Maine Medical Center and the University of Vermont are the lead organizations.
Other partners include the University of Southern Maine and the Dartmouth
CO-OP Primary Care Practice-Based Research Network. NNE-CTR’s Mission:
Enhance the health of people in northern New England (ME, NH, VT), by fostering
and coordinating clinical, translational and educational research activities.
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Additional funding supplement was received
to study the impact of opioid prescribing laws.
Prescription drug and opioid overdose has risen sharply over the last
decade and is considered one of our most pressing public health issues.
Maine is among the

TOP TEN

states with the highest
rates of opioid related
overdose deaths

In Vermont, deaths
involving opioids
increased by more
than
in 2017

1/3

85%

of deaths were caused by at least one
In Maine,
opioid including prescription and illegal drugs during 2017

Pilot Projects Awarded

29 pilot program

227

NNE-CTR participants
from Maine, Vermont
& New Hampshire

letters of intent
submitted

5 pilot projects

MMCRI At A Glance
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2018 Leadership

2018 Fast Facts

Executive Administration

203

Donald St. Germain, MD
Director & VP Research

18M

Rick McAllister, MEd
Senior Director,
Research Administration
Research Center Leadership

Paul Han, MD, MA, MPH
Director, Center for Outcomes
Research & Evaluation

Total 2018 Grant Funds

38

New Grants Awarded

200+

Clinical Trial Studies

Oncology,
Cardiology, and
Neurology

Thomas Gridley, PhD
Director, Center for
Molecular Medicine

Staff Members

264

Top 3 Clinical Research Areas

Scientific Publications
Core Facilities with State of the Art

Susan Santangelo, ScD
Director, Center for
Psychiatric Research

12

Equipment and BioBank Tissue
Repository which distributed over
3000 biospecimens

Clifford Rosen, MD
Director, Center for Clinical &
Translational Research

73
“Compositions and
methods for treating
inflammation and fibrosis”,
Dr. Peter Brooks, Dr. Leif
Oxburgh, and Jennifer Caron,
Research Associate, Brooks Lab.

Learners & Trainees in MMCRI’s
Education & Training Program

2018 Issued Patent

2018 Sources of Research Support by Sponsor Type

awarded

26%
Aging

Top 5 research topics
participants are most
interested in researching.

26%
Cancer

29%

12.0%: Industry

Substance abuse

29%

Cardiovascular
health

39%

20.6%: Foundation & Nonprofit
67.5%: Federal

Rural health
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CANCER
CENTER FOR MOLECULAR MEDICINE — LEIF OXBURGH DVM, PHD

CANCER

NEUROSCIENCE & ADDICTION

CARDIOVASCULAR & METABOLIC DISEASE

PUBLIC HEALTH

IMPROVEMENTS IN CLINICAL CARE

INTERNATIONAL TIES

FOSTERING FUTURE SCIENTISTS
https://knowledgeconnection.mainehealth.org/jmmc/vol1/iss1/20
DOI: 10.46804/2641-2225.1025

Areas of Research

Kidney Cancer
The Oxburgh laboratory is helping to fill the knowledge gap
in the field of kidney cancer thanks to the Department of
Defense Kidney Research Program award the lab received
in September 2018. Their work focuses on modeling the
effects of stroma on clear cell renal cell carcinoma, which is
the most common kidney cancer. Stroma is the connective,
functionally supportive framework of a biological tissue. The
lab will develop a system to study the interactions between
cancer cells and the normal cells that surround them. The

project will analyze the effect of the cellular environment
within the kidney on the aggressiveness of tumors. In order to
understand this better, researchers will combine tumor cells
with normal cells from kidney cancer patients and tumors of
differing aggressiveness. A promising practical result of this
work will be a means to model tumors from individual cancer
patients. This may be an important tool in personalized
medicine as it has the potential to enable testing of anticancer drug activities at the level of the individual patient.

Models of renal cell carcinoma made in the Oxburgh lab replicate what is found in human patients: Human
cancer tissue, on the left, shows unique patterning between stroma (red) and cancer (green). This patterning is
mirrored in lab-made tumor models on right. Cancer cell lines (green) pattern similarly with stromal cell lines
(red) when grown in scaffolds made from silk (blue).
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CANCER
CENTER FOR OUTCOMES RESEARCH & EVALUATION

MAINE HEALTH CANCER CARE NETWORK EXPANDING

Maine Cancer Genomics Initiative

Research Connections: MaineHealth Cancer Care Network

The Center for Outcomes Research and Evaluation
(CORE) is in the second year of a five-year initiative to lead
the outcomes evaluation component of the Maine Cancer
Genomics Initiative (MCGI). Supported by the Harold
Alfond Foundation, the MCGI is a unique collaboration
between research and clinical institutions. CORE Principal
Investigator Dr. Paul Han and Drs. Jens Reuter & Andrey
Antov from the MCGI team at Jackson Laboratory, have
partnered to study the implementation of tumor genomic
testing and downstream outcomes that will inform the
implementation of precision medicine in oncology. This
work will also develop a sustainable research-healthcare
system partnership model.

Cancer is the most common cause of death across our communities, and hundreds of caregivers from across the MaineHealth
system have come together to focus their efforts on prevention and treatment. The MaineHealth Cancer Care Network
(MHCCN) was launched in 2014 to provide comprehensive coordinated cancer care to patients across Maine. This network,
which includes 11 MaineHealth partner hospitals and organizations, offers a robust research arm, in partnership with Maine
Medical Center Research Institute and the Jackson Laboratory Cancer Center in Bar Harbor.
The network, supported by a grant from The Harold Alfond Foundation, not only provides
treatment, but prevention and education initiatives as well.

MCGI HIGHLIGHTS 2018

The MCGI is on its way to reaching the goal of providing
tumor genomic testing to 1,800 Mainers. Analyses will look
at provider and patient surveys and qualitative interviews.
The data provide information on oncologists’ use, confidence,
attitudes, and perceived barriers to implementing genomic
tumor testing, as well as patients’ beliefs and attitudes
towards the role tumor genomic tumor testing plays in their
health care journey. Together, these data play a vital role in
helping us understand how to implement tumor genomic
testing in community oncology settings, and shedding light
on physician and patient knowledge, attitudes and beliefs
towards this new technology.

494

59

15

number of
enrolled patients

participating
oncologists

participating
practices

In 2018 the MHCCN nearly doubled its number of enrolling trials, expanded its
National Cancer Institute Network Group, continued to build Maine Medical Center
based trails in specialty areas, increased its research staff by sixty percent, and
established an Oncology Protocol Review Committee.

WALDO COUNTY GENERAL
HOSPITAL, BELFAST
PEN BAY MEDICAL CENTER,
ROCKPORT

For more information about MHCCN
visit: mainehealth.org/cancer

FRANKLIN COMMUNITY HEALTH
NETWORK, FARMINGTON

18

genomic
tumor boards

LINCOLNHEALTH, DAMARISCOTTA
AND BOOTHBAY HARBOR
WESTERN MAINE HEALTH,
NORWAY
MAINEGENERAL MEDICAL
CENTER HAROLD ALFOND CENTER
FOR CANCER CARE, AUGUSTA
MID COAST HOSPITAL,
BRUNSWICK
MAINE MEDICAL CENTER,
PORTLAND
ST. MARY’S REGIONAL
MEDICAL CENTER, LEWISTON
MEMORIAL HOSPITAL,
NORTH CONWAY, NH
SOUTHERN MAINE
HEALTH CARE, BIDDEFORD
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NEUROSCIENCE & ADDICTION
CENTER FOR MOLECULAR MEDICINE — ARTURO HERNANDEZ, PHD

CENTER FOR PSYCHIATRIC RESEARCH — MATT SIEGEL, MD

Neuroendocrinology & Metabolism

Research Funding for Novel Biosensors will Help Parents of Children with Autism

The Hernandez laboratory successfully competed for a 5-year renewal of their NIH
research grant entitled “Transgenerational Epigenetic Programming of the Thyroid
axis”, funded by the National Institute of Diabetes, Digestive and Kidney Diseases.
The project aims to delineate how abnormal exposure to thyroid hormones during
development influences the endocrine function and metabolic programming in future
generations via inherited but non-genetic mechanisms. This research can shed light on
why some individuals are more likely to be susceptible to obesity and metabolic disease,
based on differences in their hormonal systems.

In October 2018, the Simons Foundation of New York, NY
and the Nancy Lurie Marks Family Foundation of Wellesley,
MA awarded Maine Medical Center Research Institute
(MMCRI) and Maine Behavioral Healthcare (MBH) a $3.1
million grant to study the use of wearable biosensors to
provide real-time warnings of impending aggression in
children with autism. Dr. Matthew Siegel, a Faculty Scientist
at MMCRI and VP of Medical Affairs for Development
Disorders at MBH is the Principal Investigator for the project.

This research study is being performed through the
Autism & Developmental Disorders Inpatient Research
Collaborative (ADDIRC), a research network of specialized
child psychiatric hospital units that serve children and
adolescents with autism and other developmental disorders.
The ADDIRC was founded in 2013 by Dr. Siegel and is
coordinated by MMCRI/MBH.

Imagine the possibilities for prevention and a family’s
quality of life if we can accurately predict that one of
these behaviors will likely happen in the next 2 minutes.
Suddenly, we are able to know when things are not
going well, provide coping strategies, and increase
safety. …Put simply, this is a potentially transformative
approach to serious problem behaviors in autism.
— Dr. Matthew Siegel
Faculty Scientist , MMCRI
VP of Medical Affairs for Development Disorders, MBH

The goal is that these watch-like devices will enable clinicians
and caregivers to predict challenging behaviors in children
with autism and create a new opportunity to intervene and
prevent problems before they occur. Current approaches
to behavioral problems in autism have primarily focused
on what happens after the behavior occurs. This three-year
clinical study will investigate whether physiology signals
such as heart rate and sweating can indicate the probability
of an impending aggressive episode, and allow people in the
environment to receive a warning.

https://knowledgeconnection.mainehealth.org/jmmc/vol1/iss1/20
DOI:910.46804/2641-2225.1025
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Dr. Siegel wearing a biosensor
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NEUROSCIENCE & ADDICTION
CENTER FOR PSYCHIATRIC RESEARCH — KRISTEN WOODBERRY, MSW, PHD

NORTHERN NEW ENGLAND CLINICAL & TRANSLATIONAL RESEARCH NETWORK RECEIVES
ADDITIONAL FUNDING IN 2018

Understanding Early Psychosis in Youth
Seventy-five percent of adult mental illnesses emerge by
age 24, with the majority appearing between ages 15 and
24. Given increasing evidence for the benefits of early
intervention, identifying predictors and indicators of
emerging mental illness is a high public health priority. In
2018, The National Institute of Mental Health (NIMH)
awarded an Exploratory/Developmental Research Grant
to new Faculty Scientist Kristen Woodberry, MSW, PhD to
collect dynamic data in adolescents and young adults at risk
for or in the early stages of severe mental illness. The project
aims to better understand the interaction of emerging
symptoms and social context over time.
Using a smartphone app, the Daily Life Study is collecting 6
mood and symptom reports a day for 21 days in 60 Boston
and Portland area youth ages 15-25. By comparing the daily
reports of those with and without psychotic symptoms, Dr.
Woodberry hopes to identify whether youth with psychotic
symptoms experience greater mood variability than their
non-psychotic peers, and whether mood variability predicts

psychotic symptoms or thoughts of self-harm. This project
is a preliminary step in a line of research examining the
interaction of mood and psychosis and identifying patterns
or sequences that can predict critical events such as suicide
attempts during the early course of major mental illness.
Early course symptom dynamics are also expected to inform
our understanding of illness progression and help develop
novel interventions to interrupt pathological sequences and
improve functional outcomes.
This project is one arm of a broader effort to build on Maine
Medical Center’s leadership role in Early Intervention in
Psychosis, initiated through the nationally-recognized
Portland Identification and Early Referral (PIER) program,
pioneered by Dr. William McFarland. Dr Woodberry is
working closely with PIER Clinical Director, Sarah Lynch,
Drs. Doug Robbins and Susan Santangelo, and Maine Health
leadership to build a regional Center of Excellence focused
on early psychosis research, training, and coordinated
specialty care.

Supporting Public Health Initiative to Fight the Opioid Crisis in rural New England
In 2016, Maine and Vermont responded to the opioid crisis
with legislation regarding opioid prescribing guidelines and
requirements for prescription drug monitoring programs. The
goal was to reduce access to opioids and make it more difficult
for patients to obtain prescriptions from multiple providers.
Through supplemental NIH funding received in 2018 by the
Northern New England Clinical and Translational Research
Network (NNE-CTR), Maine Medical Center Research
Institute (MMCRI) and its partnering institution, the
University of Vermont (UVM), are now studying the impact
that stricter opioid prescribing laws have had on population
health in northern New England.
Dr. Kathleen Fairfield of MMCRI and the Department
of Medicine at Maine Medical Center and Drs. Valerie
Harder and Timothy Plante of UVM, will analyze whether
that legislation has successfully led to a decrease in opioidrelated overdoses, hospitalizations and other medical
events and whether there were unintended consequences,
such as patients suffering from substance use disorders
turning to the illegal use of heroin instead. The team also
will analyze whether outcomes are different for various
patient demographics, such as whether they live in a rural
or urban area.

Dr. Kathleen Fairfield

While this grant provides additional funds for the NNECTR to focus on a specific issue of the opioid crisis on
our community, the Network continues to fund pilot
projects that focus on the other aspects of the opioid crisis,
highlighted on the next page.

This research provides us the opportunity to study the impact of state laws regarding
opioid prescribing while engaging with a wide variety of community members in real
time. We hope this work will help inform clinical care of patients, community-based
interventions, future policy changes and additional research.

Woodberry Research Team (L to R):
Kate Powers, Research Assistant, Dr. Woodberry, and Anna Cloutier, Research Nurse Coordinator
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— Dr. Kathleen Fairfield
MMCRI’s Lead Investigator on the NNE-CTR’s Opioid Grant
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NEUROSCIENCE & ADDICTION
NORTHERN NEW ENGLAND CLINICAL & TRANSLATIONAL RESEARCH NETWORK —
REDUCING OPIOID ABUSE
Katherine Motyl, PhD: Direct and indirect mechanisms of opioid-induced bone loss
Opioid prescription can be extremely addictive and is associated with substantial morbidity and mortality. Receipt
of prescription opioids is associated with a 3 to 4-fold increase in fracture risk. This is concerning because opioids
are often prescribed for fractures and metastatic cancer. Though opioids are associated with an increased risk of
bone fracture, the mechanisms of this risk are unclear. Dr. Katherine Motyl was awarded a pilot project in 2018
through the Northern New England Clinical & Translational Research Network (NNE-CTR) to study direct and
indirect mechanisms of opioid –induced bone loss. Dr. Motyl will test if bone loss from opioids is due to elevated
sympathetic nervous system output to bone, as well as test to see if opioids impact bone directly through interactions
with osteoclasts (a large bone cell that absorbs bone tissue during growth and healing).This work will fine tune
treatment and prevention strategies for patients who are prescribed opioids.

Kinna Thakarar, DO, MPH: Rural Harm Reduction Access and Regional Trends (Rural HeART)
Dr. Thakarar’s NNE-CTR pilot project grant seeks to examine access to harm reduction services among people who
inject drugs and are hospitalized with infectious complications. With increasing incidence of hepatitis B, hepatitis C,
and ineffective endocarditis in Maine over recent years, there are particular concerns about high-risk persons who
inject drugs in rural areas being able to access harm reduction services such as syringe site programs, which have
been shown to effectively reduce the transmission of infections, deliver overdose prevention and education, increase
vaccinations, and facilitate referrals for medication for addiction treatment.
Although the infectious complications of injection drug use (IDU) are serious and costly, relatively little attention
has been paid to characterizing the epidemiology of IDU-associated infectious complications or utilization of harm
reduction services. Results of this study will help inform future interventions to improve access to harm reduction
services in Maine and potentially other areas of northern New England.

For more information about the NNE-CTR visit: nne-ctr.net

Dr. Katherine Motyl

https://knowledgeconnection.mainehealth.org/jmmc/vol1/iss1/20
DOI:13
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CARDIOVASCULAR & METABOLIC DISEASE
CENTER FOR MOLECULAR MEDICINE — LUCY LIAW, PHD

CENTER FOR MOLECULAR MEDICINE – ILKA PINZ, PHD AND DOUG SAWYER, MD, PHD

Investigating the Causes of Cardiovascular disease

Nutrition’s Impact on Cardiovascular Disease

Why is obesity a risk factor for cardiovascular disease? This is one of the questions being addressed in a project in the Liaw
laboratory that was funded by the National Heart, Lung, and Blood Institute at the NIH in July 2018. The study focuses
on perivascular adipose tissue, which surrounds major blood vessels in the body. This adipose tissue contributes to the
cellular neighborhood of the circulatory system, and changes during obesity and metabolic disease. This project includes
collaborations between basic scientists and vascular surgeons to understand differences in this adipose tissue in patients
with varying levels of cardiovascular disease. Studies will address the interesting scientific questions of how the adipose
tissue surrounding vessels can influence or protect from disease. Because cardiovascular disease and obesity are two of the
most prevalent health issues, this research will have significant impact for a majority of the country’s population. The goal
is to understand what causes cardiovascular disease so that it can be prevented or treated more effectively.

Diet plays an important part in our overall health and in
disease prevention. However there is little research on the
impact of specific diets in patients with type 2 diabetes
mellitus (T2DM) and with ischemic heart disease (the term
given to heart problems caused by narrowed heart arteries).
Patients with T2DM and ischemic heart disease have
substantially higher chances to develop certain illnesses than
those without T2DM, and more frequently develop heart
failure. Strategies to improve glycemic control with insulin
or drugs taken orally have not impacted cardiovascular

(NRG) signaling in cardiac muscle cells. Insulin and NRG
signaling are important not only for the metabolism of sugar,
but also for survival signals in a stressed heart. Drs. Ilka Pinz
and Douglas Sawyer received a pilot project award from
MMCRI’s Center of Biomedical Excellence in Metabolic
Networks in late 2018 to study nutrition’s impact on type
2 diabetic patients with heart disease. They will test how
short-term Mediterranean diet consumption changes the fat
composition of cardiac muscle cells and thus protects insulin
and NRG signaling in humans. This work will increase

Artherosclerotic Plaque

Progenitor cells surrounding blood vessels can be collected
from patients with cardiovascular disease and studied in the
lab for their ability to become adipocytes, or fat cells. Image
shows human progenitor cells grown as three dimensional
aggregates and programmed to become adipocytes. The
resulting “adipospheres” show green staining of lipids, red
staining of perilipin1, a lipid droplet-associated protein,
and blue stained nuclei. This adiposphere model allows us
to better mimic human fat tissue in the research lab.

disease and mortality outcomes in T2DM patients with
known heart disease. Our research in mice and humans
has shown that a western style diet with a high amount of
saturated fat impairs not only insulin but also neuregulin
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our understanding of the molecular pathology that dietary
choices influence and will help to develop new treatments
for type 2 diabetic patients with heart disease.
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CARDIOVASCULAR & METABOLIC DISEASE
NORTHERN NEW ENGLAND CLINICAL & TRANSLATIONAL RESEARCH NETWORK
Teresa May, DO: Opioid and Non-opioid Related Cardiac Arrest Outcomes in Northern New England
Cardiac arrest is the third leading cause of death in
North America, with great variation in survival rates in
different regions of the U.S. These differences may be
due to factors related to the patients, emergency medical
services, or hospitals. Dr. May was awarded a pilot project
in 2018 through the Northern New England Clinical &
Translational Research Network to study these factors across
the states of Maine, New Hampshire and Vermont. Other
factors that may influence patient outcomes are whether
the cardiac arrest is related to opioid use, and whether the
patient suffering the arrest lives in a rural or more populated
region. Dr. May will study variations in the provision of
health services and patient outcomes for both opioid related
and non-opioid related cardiac arrest, broken down by
geographic region throughout Maine, New Hampshire and
Vermont. Dr. May’s work will help define the geographic
barriers to cardiac arrest care throughout Northern New
England, and should help impact care for cardiac arrest
patients in the current opioid epidemic, affording the
opportunity to improve clinical outcomes in the region in
both opioid related and non-opioid related cardiac arrest.

Research in Metabolic Disease
Publication in scientific journals is a key way that scientists share their results with the scientific community. MMCRI
investigators had 264 publications in 2018. Two of those reported exciting breakthroughs in major scientific publications
and are highlighted below.
Cliff Rosen, MD, Director of the Center for Clinical &
Translational Research, in collaboration with scientists at
the Dana-Farber Cancer Institute and other organizations,
has discovered that irisin, a hormone released by muscles
during exercise, directly acts on key regulatory cells that
control the breakdown and formation of bone, raising the
prospect of new treatments for bone-thinning disorders like
osteoporosis. This research was published in December 2018
in the journal Cell.

Aaron Brown, PhD, reported in the journal Cell Reports
(December 2018) that an anti-diabetic fat generated in the lab
could be used to help develop new drugs and treatments for
diabetic and obese patients. For example, long-term, this fat
could be transplanted into patients to burn calories or secrete
anti-diabetic molecules that alleviate the disease. Researchers
in Dr. Brown’s lab plan to first test the anti-diabetic fat by
transplanting it in mouse models of obesity and diabetes prior
to human studies. The work was funded in large part through
MMCRI’s COBRE award entitled “Mesenchymal and Neural
Regulation of Metabolic Networks.”

Dr. Cliff Rosen
For more information about the NNE-CTR visit: nne-ctr.net

https://knowledgeconnection.mainehealth.org/jmmc/vol1/iss1/20
DOI:17
10.46804/2641-2225.1025
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PUBLIC HEALTH
VECTOR-BORNE DISEASE LABORATORY
A Surge in Anaplasmosis

Earlier Diagnosis of Lyme Disease

Cases of anaplasmosis, a tick borne infection that is particularly severe in the elderly, dramatically increased in Maine over
the past 5 years (Figure 1). With the assistance of a private donation, the Vector-borne Disease Laboratory team launched
a project to determine if risk of infection varies geographically in Maine by testing ticks collected from northern and
southern tiers of the state. In addition, parallel research investigated patterns of disease diagnosis and the frequency of
hospitalization, in order to gain a better understanding of the causes of the observed increase in cases. The goal is that
this knowledge will lead to more focused public health approaches to the prevention of anaplasmosis.

Dr. Robert Smith and Research Associate Susan Elias began a collaboration with the company MicroBPlex on a National
Institutes of Health funded project in 2018 to examine the effectiveness of a diagnostic test to aid in the detection of early
Lyme disease in patients in southern Maine. This project will expand in 2019 to involve three geographic areas in Maine:
Greater Portland, with Maine Medical Center Research Institute as coordinator; Mid-coast Maine with a study center at Pen
Bay Medical Center; and southern Maine at Southern Maine Health Care. A clinical site associated with Johns Hopkins
Medical Center in Baltimore is also a partner. This novel approach to diagnosis may lead to earlier confirmation of Lyme
disease, as well as the possibility of distinguishing past from current infection. The linkage of several different clinical sites
in Maine for studies of tick borne disease is a promising prototype for future diagnostic and treatment trials.

A Focus on Disease Carrying Mosquitos
With support from a Maine Centers for Disease Control
grant, Research Assistant Margret Welch and vector
ecologist Charles Lubelczyk established an insectary in
cooperation with the University of Southern Maine in
Gorham to test the development of pesticide resistance
in native species of mosquitoes that are of medical or
veterinary importance. Testing for pesticide susceptibility
will include vector mosquitoes from across geographic
regions in Maine. This movement of a new mosquito
species capable of transmitting disease in Maine, coupled
with the recognition of the mosquito-transmitted virus
(Jamestown Canyon virus), is of great concern, and the lab’s
mosquito surveillance program, guided by Lubelczyk and
Field Biologist Libby Henderson, is integrating this study
with other studies on the effectiveness of chemical controls
and public and veterinary risks of mosquito-borne disease.

Chuck Lubelczyk, Vector Ecologist
for MMCRI, completing field work.
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PUBLIC HEALTH
CENTER FOR OUTCOMES RESEARCH & EVALUATION

NORTHERN NEW ENGLAND CLINICAL & TRANSLATIONAL RESEARCH NETWORK

Maine Lung Cancer Coalition: a statewide collaboration

Improving Health in Rural Communities across New England

The Maine Lung Cancer Coalition (MLCC) is a 4-year
statewide, multi-institution, multi-disciplinary initiative
begun in August 2016, with funding from the Bristol Myers
Squibb Foundation, with the goals of improving lung
cancer prevention, early detection, stakeholder education,
and research and data analytics for a better understanding
of lung cancer determinants, disparities, and outcomes.
MMCRI is the lead institution for the Coalition, which
is led by Dr. Paul Han (Principal Investigator), Dr. Neil
Korsen (Co-PI), and Leo Waterston (Project Director). The
MLCC brings together diverse stakeholders across Maine
to work together to reduce suffering and death from lung
cancer, with a special focus on vulnerable rural populations
with limited access to health care.

Over 60 percent of Maine’s population lives in a rural
area and Maine is the 2nd most rural state in the nation
(based on population density). The Northern New England
Clinical and Translational Research Network (NNE-CTR)
was established in July 2017 to enhance the health of people
in northern New England (ME, NH, VT) by fostering
and coordinating clinical, translational and educational
research activities.

The MLCC, through its partner the MaineHealth Center
for Tobacco Independence, received a grant for $30,000 in
2018 from Anthem Blue Cross and Blue Shield Foundation

to integrate evidence-based smoking cessation treatment
into lung cancer screening. The project targets older, heavy
smokers residing in rural Maine who are at high lung cancer
risk and have been referred for lung cancer screening with
low-dose CAT or CT scan (LDCT).
Other highlights in 2018 include launching pilot projects
to generate evidence on ways of improving access to lung
cancer prevention and screening services to populations
in Maine. These projects include studies of the geographic
burden of lung cancer and utilization of lung cancer
screening and treatment services; community members’
perceptions and attitudes regarding lung cancer risk and
prevention; use of telemedicine to conduct shared decision
making consultations for lung cancer screening; and a
statewide survey of primary care physicians’ knowledge
and attitudes regarding lung cancer screening.

One key goal of the NNE-CTR is to bring clinical and
translational research opportunities to rural communities
in Maine. Dr. Neil Korsen is leading this effort in Maine
through the Rural Health Research and Delivery Core,
which has begun to build partnerships with rural clinicians
and practices to increase their participation in clinical
trials. Dr. Korsen has also worked with rural clinicians
to help them develop their own research ideas, providing
technical assistance as needed.
The Rural Core is working closely with two rural
communities in Maine: Western Maine Health in the
Oxford County area and Pen Bay Medical Center on the
Maine coast in Rockport. To connect the community with

For more information about the MLCC, visit: mainelungcancercoalition.org
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clinicians and researchers in the Oxford County Area, the
Rural Core sponsored a community symposium: Building
Partnerships for Rural Health Research in June 2018. The
event was attended by 40 participants including researchers,
clinicians and community members. The Rural Core is
now working with a subset of symposium participants to
develop a research project targeting individuals impacted
by Adverse Childhood Experiences.

Rural Core Team (L to R): Project Manager, Lisbeth Wierda,
MPH, Dr. Korsen, and Research Navigator, Kerri Barton, MPH.

For more information on the NNE-CTR and the Rural Core, visit: nne-ctr.net
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IMPROVEMENTS IN CLINICAL CARE
The Cystic Fibrosis Foundation Awards
MMC $1.1M for Multi-Center Study

Dr. David Seder, MD: Stroke Study
Continues to Make Progress

In July of 2018, the Cystic Fibrosis Foundation awarded
Maine Medical Center $1.1M for a multi-center study
investigating complications associated with use of midline
and peripherally inserted central venous catheters (PICCs) in
Cystic Fibrosis (CF) patients. Cystic Fibrosis is a progressive,
genetic disease that causes lung infections which often
require repeated courses of intravenous antibiotics through
PICCs or midline catheters. A range of adverse events
such as clots, infection and permanent distortion of blood
vessels can arise from use of these catheters. Identifying
risk factors for these complications should help healthcare
providers prevent injury and improve overall outcomes in
this vulnerable population. Dr. Jonathan Zuckerman, Maine
Medical Center and Dr. Alex Gifford, Dartmouth-Hitchcock
Medical Center, are the lead Principal Investigators for
the project. “To date, no multicenter study has carefully
investigated these complications in a large, diverse group of
adult and pediatric CF patients. We are excited to leverage
the resources and talents available through Maine Medical
Center Research Institute to coordinate such a large effort,”
said Dr. Zuckerman. The study will include 10 sites across
the United States and span 3 years.

SETPOINT2 is an international, multi-site clinical trial
to improve outcomes for patients who have suffered a
severe stroke by assessing the best timing of tracheostomies.
Heading this study is Dr. David Seder, the U.S. Principal
Investigator (Maine Medical Center), along with Dr. Julian
Bösel, the German Principal Investigator (Kassel University
Hospital). SETPOINT2 stands for Stroke-Related Early
Tracheostomy vs Prolonged Orotracheal Intubation in
Neurocritcal Care Trial2.

Alexa Craig, MD: Improving Neonatal Care
Dr. Craig, Neonatal and Pediatric Neurologist, was awarded
a pilot project in 2018 through the Northern New England
Clinical and Translational Research Network (NNE-CTR)
to study ways to improve the detection of and treatment
for neonatal encephalopathy in rural areas. Neonatal
encephalopathy is a type of brain injury that can occur in
newborn infants due to lack of oxygen and blood flow to the
brain around the time of birth.
Therapeutic hypothermia is the only known treatment for
neonatal encephalopathy; this involves placing the baby on
a cooling blanket that maintains a temperature of 91 degrees
Fahrenheit for 72 hours followed by 12 hours of rewarming.
The baby is monitored in an intensive care unit during this
treatment and magnetic resonance imaging is then performed
to determine presence or absence of brain injury.

One of the clinical challenges of this treatment is that it must be started within the first six hours of life, and earlier
treatment is known to be associated with improved outcomes. For the 75 percent of infants treated with hypothermia
who are born in rural Maine hospitals, recognizing neonatal encephalopathy and getting the baby cooled quickly
are particular challenges, especially for providers in rural locations who do not see these babies all that often.
Dr. David Seder

— Dr. Alexa Craig
Neonatal and Pediatric Neurologist

A peripherally inserted central
venous catheters (PICC) Close Up

The study is entering its third year, and 2018 marked
considerable growth with patient enrollment and new
site activations. The SETPOINT2 findings could benefit
patients because the timing of a tracheostomy may affect
the amount of sedating medications that is required, and
could affect brain recovery and the body’s ability to return
to pre-stroke activities. Preliminary studies suggest it could
be beneficial to perform a reversible tracheostomy procedure
earlier than is usually done after severe stroke (within the
first 5 days), as opposed to delaying more than 10 days before
performing the procedure.
For more information on this study, visit: picccf.org

Dr. Alexa Craig

To combat these challenges, Dr. Craig developed her
NNE-CTR pilot study to employ a telemedicine consult, a
three-way, real-time interactive communication via video
between the rural physician, the neonatologist at MMC
and Dr. Craig. For infants and their families, this means
faster diagnosis and treatment via a live consultation, thereby
improving their chances of a better outcome or avoiding
unnecessary treatment. Dr. Craig will assess the results of
her pilot project in the next year to determine if the realtime consultations successfully decrease the time to initiate
therapeutic hypothermia.

For more information about the NNE-CTR visit: nne-ctr.net

For more information on this study, visit: setpoint2.org

Published
MaineHealth
Knowledge
Connection,
2019
MEDICAL
CENTER RESEARCH
INSTITUTE:
2018 YEAR IN REVIEW
23 byMAINE

MAINE MEDICAL CENTER RESEARCH INSTITUTE: 2018 YEAR IN REVIEW

24 13

Journal of Maine Medical Center, Vol. 1 [2019], Iss. 1, Art. 20

INTERNATIONAL TIES
Scot Remick, MD: Developing Training &
Research Infrastructure in Kenya
The burdens of cancer and cerebrovascular disease --a
group of conditions that can lead to a cerebrovascular
event, such as a stroke-- are major causes of morbidity
and mortality in Kenya. Kenya’s limited research
infrastructure and significant scarcity of doctors to
address these increasing chronic threats are a major
challenge to public health. With funding by the National
Institutes of Health Fogarty International Center, an
international team of highly interactive and experienced
Pediatric Palliative Care and End of Life Training
investigators is addressing these issues by developing
Workshop July 2018, Kenyatta National Hospital,
vital training and research infrastructure, evidenceNairobi, Kenya
based approaches for intervention, and public health
policy. The team, led by Dr. Scot Remick, Chief of
MaineHealth Oncology & Clinical Investigator at Maine Medical Center Research Institute, includes senior Kenyan
collaborator Dr. Walter Mwanda, University of Nairobi; Ms. Anne Korir and Dr. Lydia Kaduka at the Nairobi Cancer
Registry and Kenya Medical Research Institute in Nairobi; and Dr. Patrick Loehrer at Indiana University and his Kenyan
collaborator Dr. Nathan Buziba, Moi University in Eldoret. This diverse team is working to develop sustainable research
capacity for cancer and cerebrovascular disease control in Kenya across the lifespan.
To date the team has trained 8 stroke {Non-Communicable Disease (NCDs)] registrars; successfully launched and
completed the first-ever NCD Stroke Registry in Sub-Saharan Africa; supported one post-doctoral training and PhD
candidate for health policy in cerebrovascular disease and cancer epidemiology respectively; supported five early-career
Kenyan trainees in the Department of Hematology and Blood Transfusion to satisfy requirements for three Pathology
and two Clinical Cytology masters degrees; trained two physicians in palliative care medicine with a focus on end-of-life
care in the pediatric setting; and sponsored a workshop that trained more than 30 healthcare professionals in pediatric
palliative and end-of-life care. Dr. Remick and his colleagues hope to compete for successor NIH Fogarty International
Center funding to build on the success of the current project.
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Susan Miesfeldt, MD: Improving Palliative
Care in Tanzania
Nearly 80% of those diagnosed with cancer in Tanzania
die from their disease due to limited numbers of
adequately resourced cancer care facilities. As a result,
access to effective palliative care is a critical public
health priority in Tanzania, and Africa as a whole, and
the need for innovative community-based solutions is
highly recognized. Palliative care in the cancer patient
is focused on improving quality of life by relieving pain
and other distressing symptoms as well as addressing
emotional, social and spiritual needs. Although there
Dr. Miesfeldt and research team during usability
are few palliative care specialists in Tanzania, mobile
testing.
technology holds promise in improving communitybased access to care by linking the limited pool of
specialists with patients, caregivers, and local health workers. Dr. Susan Miesfeldt, Clinician Investigator at MMCRI,
received funding from the National Institutes of Health Fogarty International Center in late 2017, to develop an
innovative community-based mobile health solution to a limited palliative care workforce. The overall goal is to develop
and test a mobile phone-based symptom assessment/control communication application (m-Palliative Care Link;
mPCL) that remotely facilitates symptom self-reporting among late-stage cancer patients and communication between
patients, local health workers and specialists, aimed at effective information exchange and reduced symptom burden.
In the first year of funding, partnering with US-based software engineers and Tanzanian researchers and clinicians,
the team has completed mPCL development and usability testing. In the second and final year of funding, they will
complete an mPCL pilot test among 45 Tanzanian late-stage cancer patients. By working with existing personnel and
technology, this work promises to result in a sustainable and scalable means to support high quality, patient-centered
symptom assessment and control in Tanzania and other low-resource countries, relevant not only to cancer patients
but other chronic diseases patients as well.
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INTERNATIONAL TIES
Research Goes Global

VISITING SCHOLARS

Research is a global endeavor at Maine Medical Center
Research Institute and the Institute has welcomed
research scholars from other countries for many years.
In September two scholars from Lund University
School of Medicine in Sweden came to participate
in a research collaboration with physician scientists
in Critical Care Medicine at Maine Medical Center.
Ameldina Bilkanovic and Zana Haxhija, who are in
their final year of medical school, traveled to Portland
to collaborate for three months with David Seder, MD,
and the neurocritical care research team on a project
related to the International Cardiac Arrest Registry
Database. Zana and Ameldina also worked with Sarah
Peterson, MD, PhD in the Sawyer Ryzhov Lab on basic
science and translational research. Biostatistician Lee
Lucas RN, PhD from the Center for Outcomes Research
and Evaluation worked with Zana and Ameldina on the
biostatistical elements of the project. The students had
a robust research experience and felt that their time
in the U.S. was well-spent. “We gained so much! We
learned a lot about our project and a lot about ourselves,
living away from home. Combining research and rounds
helped us to see how healthcare works here in the U.S.,”
said Zana. “It helped me to confirm that critical care is
an area I would like to go into,” says Ameldina. Zana and
Ameldina worked on two manuscripts during their time
at MMC and will present their research at their home
university in Sweden upon their return.

Ashwani Gupta, PhD Postdoctoral Fellow —
Oxburgh Lab

Ashwani Gupta, PhD

Ashwani came to MMCRI from Sanjay Gandhi
Postgraduate Institute of Medical Sciences, Lucknow,
Uttar Pradesh, India. He joined the Oxburgh Lab in
2016 to focus on kidney research in an area that may be
instrumental in kidney repair or replacement. Specifically
the Oxburgh Lab is doing research to make kidney tissue
from skin derived cells and testing their functionality. The
preliminary data looks promising and Ashwani is looking
forward to continuing his work in kidney research.

Yosta Vegting — Rosen Lab
Yosta is a medical student from the University of Amsterdam
in the Netherlands. She came to MMCRI in 2018 to
participate in research collaboration before graduating. Yosta
is in the Rosen Lab doing research on a newly discovered
hormone called irisin. Irisin is made by muscles when
exercising and could help to build our knowledge as to why
exercising is healthy. Yosta is looking forward to using the
research techniques learned at MMCRI to pursue her PhD.

Zana Haxhija (left) and Ameldina Bilkanovic (right)
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FOSTERING FUTURE SCIENTISTS
Education & Training Fast Facts

14
6

Rotating & full-time graduate students
Research fellows

40

Academic interns, over:

13

labs & research areas

5

International visiting scholars

3

Maine Medical Center residents

5

Student employees

Advancing Maine’s High
School Science Curriculum
In June 2018, Maine Medical Center Research Institute
was awarded $10K from the Celia Lipton Farris & Victor
W. Farris Foundation Home Community of the Maine
Community Foundation to expand its current high school
program, called NextGen, to other high schools throughout
Maine. The grant funding is being used to create a handson science and research curriculum pilot program for high
school classrooms.
MMCRI currently offers a high school education program
to a small number of Maine schools. Students and teachers
travel to MMCRI once a month for a seven session-program
to learn about biomedical research through experiential
learning activities. The program created with this grant
funding will allow schools to benefit from the MMCRI
program for less money and with less travel.

MMCRI Summer Student Research Program Expands Opportunities for Underrepresented Students
This past summer MMCRI’s Summer Student Research Program (SSRP) had a record number of summer interns. This
was in part due to an undergraduate research award in 2018 from the American Heart Association, designed to enhance
the diversity of college student research interns at Maine Medical Center. There are many opportunities in Maine to reach
students from groups that are underrepresented in STEM careers, which is the focus of this effort. In Maine there are a
large number of students from rural and economically disadvantaged communities, a growing immigrant population, and
a state university system where approximately one-half of the students are first generation college students. In an attempt to
measure diversity, students were provided with an optional demographic information collection sheet. Data was also analyzed
to determine if students were from a rural Maine county, from one that has a higher than state average of free or reduced
lunch, or from one in which the population has a higher than state average of people with a high school diploma or less.
Moving forward, the goal will be to develop proactive measures to continue to help identify students from underrepresented
groups, expanding opportunities and engagement for all SRRP students.

MMCRI researchers and staff are working collaboratively
with several educators and using lessons from the current
high school program to create portable kits for classrooms
which will include a detailed on-line science curriculum
and videos.

Developing and giving access to this curriculum is
exciting for us, as are the possibilities that lie ahead
for this program. Careers in science and technology
are high growth areas in Maine, and programs like
these expose and engage students early.
High school student Lucy Hartley gets a
chance to experience hands on lab work.
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— Lucy Liaw, PhD
MMCRI Senior Scientist
Director of Education and Training

2018 Summer Student Research Program Participants
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Support
Our Research
MMCRI is already one of the most innovative research
organizations in the nation.
With your help, we can achieve even more.
By donating to MMCRI, you help bring the latest scientific
discoveries to the bedside and improve the quality of care patients
receive. Today’s groundbreaking study could be tomorrow’s lifesaving treatment. Your gift will help support research projects that
further our understanding of disease processes, which enables us
to develop better diagnostics and treatment.
Areas of opportunity for support of our laboratory-based or clinical research projects include: Cardiovascular
Disease, Cancer, Bone and Mineral Disease, Molecular Biology and Genetics, Clinical Trials, Psychiatric Research,
and Vector Borne Diseases.
Our efforts go beyond research, as well: by supporting our summer scholarships, you will help us educate and cultivate
the next generation of researchers, and ensure that the quest for knowledge and insight continues for years to come.
If you’re interested in supporting the work of Maine Medical Center Research Institute, please contact
Kristen Crean of the Philanthropy Department at (207) 662-3895 or by email at kcrean@mmc.org.

81 Research Drive ∙ Scarborough, ME 04074
 (207) 396-8100
mmcri.org
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